InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

SHOULDER INNOVATIONS, INC.

SI Clue Score60
United States Fiscal year ends December CIK 0001699350 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

33
Insider
Date
Role
Action
Shares
Price
Amount
Robert Joseph Ball
30 Oct 2026
CEO & Executive Chairman
Exercised, kept
66,757
$2.48
$165.58K
Robert Joseph Ball
14 Sep 2026
CEO & Executive Chairman
Sold after exercise
10,175
$18.45
$187.71K
Gilde Healthcare Holding B.V.
26 Aug 2026
10% owner
Sell indirect
1,196
$22.60
$27.03K
Gilde Healthcare Holding B.V.
24 Aug 2026
10% owner
Sell indirect
681
$22.62
$15.40K
Gilde Healthcare Holding B.V.
21 Aug 2026
10% owner
Sell indirect
20,516
$22.61
$463.87K
Gilde Healthcare Holding B.V.
20 Aug 2026
10% owner
Sell indirect
3,900
$22.60
$88.14K
Matthew Fraser Ahearn
18 Aug 2026
Chief Operating Officer
Sold on a plan
1,600
$21.38
$34.21K
Matthew Fraser Ahearn
18 Aug 2026
Chief Operating Officer
Sold on a plan
12,586
$20.94
$263.49K
Matthew Fraser Ahearn
17 Aug 2026
Chief Operating Officer
Sold on a plan
8,314
$20.10
$167.10K
Gilde Healthcare Holding B.V.
6 Aug 2026
10% owner
Sell indirect
2,095
$22.60
$47.35K
Gilde Healthcare Holding B.V.
5 Aug 2026
10% owner
Sell indirect
7,338
$22.64
$166.13K
Gilde Healthcare Holding B.V.
4 Aug 2026
10% owner
Sell indirect
99,812
$22.77
$2.27M
Gilde Healthcare Holding B.V.
3 Aug 2026
10% owner
Sell indirect
10,751
$22.71
$244.16K
Gilde Healthcare Holding B.V.
31 Jul 2026
10% owner
Sell indirect
20,034
$22.73
$455.37K
Gilde Healthcare Holding B.V.
30 Jul 2026
10% owner
Sell indirect
28,245
$23.36
$659.80K
Matthew Fraser Ahearn
15 Jun 2026
Chief Operating Officer
Sold on a plan
2,500
$19.26
$48.15K
Matthew Fraser Ahearn
15 Jun 2026
Chief Operating Officer
Sold on a plan
1,644
$18.20
$29.92K
Matthew Fraser Ahearn
12 Jun 2026
Chief Operating Officer
Sold on a plan
15,856
$18.68
$296.19K
Robert Joseph Ball
30 Apr 2026
CEO & Executive Chairman
Exercised, kept
10,000
$2.48
$24.80K
Matthew Fraser Ahearn
20 Apr 2026
Chief Operating Officer
Exercised, kept
14,243
$2.86
$40.76K
Matthew Fraser Ahearn
20 Apr 2026
Chief Operating Officer
Exercised, kept
7,421
$2.48
$18.41K
Robert Joseph Ball
13 Mar 2026
CEO & Executive Chairman
Buy
2,200
$15.18
$33.39K
Richard Buchholz
13 Mar 2026
Director
Buy
1,000
$14.84
$14.84K
Paul Buckman
13 Mar 2026
Director
Exercised, kept
26,205
$2.10
$55.00K
Paul Buckman
13 Mar 2026
Director
Exercised, kept
19,401
$2.48
$48.12K
Jeffrey S. Points
13 Mar 2026
Chief Financial Officer
Buy
2,000
$15.00
$30.00K
Jeffrey S. Points
13 Mar 2026
Chief Financial Officer
Exercised, kept
13,264
$2.48
$32.90K
Robert Joseph Ball
6 Feb 2026
CEO & Executive Chairman
Exercised, kept
2,062
$2.10
$4.33K
Robert Joseph Ball
6 Feb 2026
CEO & Executive Chairman
Exercised, kept
10,000
$2.48
$24.80K
Robert Joseph Ball
12 Dec 2025
CEO & Executive Chairman
Buy
3,900
$14.89
$58.08K
Jeffrey S. Points
12 Dec 2025
Chief Financial Officer
Buy
1,005
$14.98
$15.05K
Robert Joseph Ball
11 Dec 2025
CEO & Executive Chairman
Buy
3,300
$14.83
$48.93K
Jeffrey S. Points
11 Dec 2025
Chief Financial Officer
Buy
995
$14.65
$14.58K

What was left out

Form 4 filings counted 35
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 6
Sales straight out of an exercise 1
Sales at will 10
Transactions with no price 0
Shares from compensation/vesting 330,785
History held since 5 Aug 2025